TELA
TELA
NASDAQ · Health Care

Tela Bio Inc

$0.86
-0.08 (-8.69%)
As of Nov 14, 2:39 AM ET ·
Financial Highlights (FY 2026)
Revenue
71.88M
Net Income
-34,767,610
Gross Margin
67.7%
Profit Margin
-48.4%
Rev Growth
+24.7%
D/E Ratio
8.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 71.88M 57.65M 7.47M 7.60M
Gross Profit 48.65M 39.02M 2.11M 2.15M
Operating Income -31,021,940 -22,393,123 1.36M 1.26M
Net Income -34,767,610 -25,096,927 1.27M 1.28M
Gross Margin 67.7% 67.7% 28.2% 28.2%
Operating Margin -43.2% -38.8% 18.2% 16.6%
Profit Margin -48.4% -46.0% 17.0% 16.9%
Rev Growth +24.7% +24.7% +18.1% +22.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 16.23M 16.23M 9.64M 8.55M
Total Equity 1.84M 1.84M 26.51M 24.38M
D/E Ratio 8.82 8.82 0.36 0.35
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -30,454,761 -23,205,023 2.01M 2.00M
Free Cash Flow — — 1.14M 1.46M